Opportunities and challenges provided by crosstalk between signalling pathways in cancer.
about
Using Big Data to Discover Diagnostics and Therapeutics for Gastrointestinal and Liver Diseases.In Vitro Antileukemia Activity of ZSTK474 on K562 and Multidrug Resistant K562/A02 Cells.Targeting tumor suppressor genes for cancer therapy.Immuno-Oncology Integrative Networks: Elucidating the Influences of Osteosarcoma Phenotypes.Ranking Differential Drug Activities from Dose-Response Synthetic Lethality Screens.Conceptual and computational framework for logical modelling of biological networks deregulated in diseases.A phosphokinome-based screen uncovers new drug synergies for cancer driven by liver-specific gain of nononcogenic receptor tyrosine kinases.
P2860
Q31138564-B584C2F9-CC7E-48EF-B0DA-F77C7CA6F683Q36911063-5E71A263-361B-4170-81E4-3DC65CC22B40Q38601568-49BB2466-3C3B-4279-8688-052A55E14F2AQ38626906-D45961B1-1F5A-434A-B937-53308ECDE194Q39823855-AC74613F-1E16-4AD4-91F7-F3ECE62ACFA1Q47316698-A678312B-47AD-49D8-BA61-6233FAB334FAQ48321277-389432D0-AB74-466D-A20A-EA875390CFFD
P2860
Opportunities and challenges provided by crosstalk between signalling pathways in cancer.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Opportunities and challenges provided by crosstalk between signalling pathways in cancer.
@en
type
label
Opportunities and challenges provided by crosstalk between signalling pathways in cancer.
@en
prefLabel
Opportunities and challenges provided by crosstalk between signalling pathways in cancer.
@en
P2860
P356
P1433
P1476
Opportunities and challenges provided by crosstalk between signalling pathways in cancer.
@en
P2093
A Prahallad
P2860
P2888
P304
P356
10.1038/ONC.2015.151
P407
P577
2015-05-18T00:00:00Z
P5875
P6179
1021485255